In February 2024, Dr. Sonya Faber presented in Boston for the Cambridge Health Alliance with leading experts in the field. She discussed the importance of culturally-informed psychedelic therapy.
"I feel this topic is utterly essential and important. I was glad that Dr. Faber shared about her work, and the way diversity and inclusion needs to be addressed in this field." - Participant feedback
Faber, S. C. (2023, July 27). Expecting Adversity in Academia. Keynote Lecture. Black Journey To Neuro Week, Black in Neuroscience, USA & Canada.
Faber S. C. (2023, September 9). Implicit bias in psychedelic therapy. Center for Psychedelic Studies, Naropa University, USA.
Faber S. C. (2024, February 10). Embracing Diversity and Inclusion in Psychedelics Work. Psychedelic-Assisted Psychotherapy: Contrasting Visions. Harvard Medical School, Boston, MA.
In August 2022, Dr. Sonya Faber was joined in Germany by the leading North American diversity expert, Dr. Monnica Williams, for this riveting talk for the Max Planck Institute about how microaggressions impede the realization of diversity and equity goals in science. People of color, women, and immigrants are subject to different types of stereotypes, giving rise to different types of covert bias.
Faber, S. C. (2022, September 26). The Importance of Cultural Competency and Anti-Racist Education for Psychedelic Assisted Therapy: Understanding Aversive Racism and the Power of Identity. [Virtual]. Diversity, Culture and Social Justice in Psychedelics Course, Chacruna Institute, San Francisco, CA, USA.
Faber, S. C. (2022, September 22-24). The Importance of Cultural Competency and Anti-Racist Education for Psychedelic Assisted Therapy — Understanding Aversive Racism. Interdisciplinary Conference on Psychedelic Research (ICPR), Haarlem/Amsterdam, The Netherlands.
Faber, S. C. & Williams, M. T. (2022, August 10). Microaggressions in Research Spaces. IDEA Seminar. Max Planck Institute, Munich, Germany.
Faber, I., Faber, S., & Williams, M. T. (2022, June 15). A call to use psychology for anti-racist jury selection. The British Psychological Society, Division of Forensic Psychology Annual Conference, June 4 - 16, 2022, Voco St. John's, Solihull, UK.
Faber, S. C. (2022, June 7). First, do no harm. From childhood socialization to micro aggressions — recognizing implicit bias and nurturing allyship. Grand Rounds, Department of Medicine, The Ottawa Hospital, University of Ottawa, ON, Canada.
Faber, S. C. (2022, June 6). Racism, Science, Spirituality and Love. Graduate guest lecture, Department of Classics and Religious Studies, University of Ottawa, Ottawa, ON, Canada.
Faber, S. C. (2022, May 30). Cultural Competency in Psychedelic Assisted Therapy. [Virtual]. Diversity, Culture and Social Justice in Psychedelics Course, Chacruna Institute, San Francisco, CA, USA.
Faber, S. C. & Smith, D. (2022, May 29). The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of its Provision Burdens of Provision. From Research to Reality (R2R) Global Summit on Psychedelic Assisted Therapies and Medicine, Toronto, ON, Canada.
Faber, S. C. (2022, May 17). Cultural Competency in Psychedelic Assisted Therapy: What are the requirements? [Virtual]. Diversity, Culture and Social Justice in Psychedelics Course, Chacruna Institute, San Francisco, CA, USA.
Faber, S. C. (2022, February). Preparing for Adversity as a Black Professional / Celebrating Black History Month. [virtual]. Canadian Psychological Association.
Williams, M. T. & Faber, S. C. (2019, July). Culturally-informed clinical research: Assessment, recruitment, interventions & ethics. World Congress of Behavioral and Cognitive Therapies, Berlin, Germany.
Faber, S. C., Williams, M. T., & Terwilliger, P. R. (2019, July). Implicit racial bias across ethnic groups and cross-nationally: Mental health implications. In M. Williams & N. Buchanan, Racial issues in the assessment of mental health and delivery of cognitive behavioral therapies. World Congress of Behavioral and Cognitive Therapies (WCBCT), Berlin, Germany.
Patel, A., Gil-Nagel, A., Chin, R., Mitchell, W., Perry, S. M., Weinstock, A., Whyte, L., VanLandingham, K. (2019, May) Longterm Safety and Efficacy of Add-on Cannabidiol Treatment in Patients with Lennox-Gastaut Syndrome in an Open-label Extension Trial, 54th DGfE Congress, Basel Switzerland.
